Literature DB >> 18200674

Comparison of real-time polymerase chain reaction with the COBAS Amplicor test for quantitation of hepatitis B virus DNA in serum samples.

Ming Shi1, Yong Zhang, Ying-Hua Zhu, Jing Zhang, Wei-Jia Xu.   

Abstract

AIM: To compare the clinical performance of a real-time PCR assay with the COBAS Amplicor Hepatitis B Virus (HBV) Monitor test for quantitation of HBV DNA in serum samples.
METHODS: The reference sera of the Chinese National Institute for the Control of Pharmaceutical and Biological Products and the National Center for Clinical Laboratories of China, and 158 clinical serum samples were used in this study. The linearity, accuracy, reproducibility, assay time, and costs of the real-time PCR were evaluated and compared with those of the Cobas Amplicor test.
RESULTS: The intra-assay and inter-assay variations of the real-time PCR ranged from 0.3% to 3.8% and 1.4% to 8.1%, respectively. The HBV DNA levels measured by the real-time PCR correlated very well with those obtained with the COBAS Amplicor test (r = 0.948). The real-time PCR HBV DNA kit was much cheaper and had a wider dynamic range.
CONCLUSION: The real-time PCR assay is an excellent tool for monitoring of HBV DNA levels in patients with chronic hepatitis B.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18200674      PMCID: PMC2679140          DOI: 10.3748/wjg.14.479

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  A convenient approach to the generation of multiple internal control DNA for a panel of real-time PCR assays.

Authors:  Markus Stöcher; Victoria Leb; Jörg Berg
Journal:  J Virol Methods       Date:  2003-03       Impact factor: 2.014

Review 2.  Hepatitis B virus. The major etiology of hepatocellular carcinoma.

Authors:  R P Beasley
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

3.  Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays.

Authors:  S D Pas; E Fries; R A De Man; A D Osterhaus; H G Niesters
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

4.  Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection.

Authors:  Henry Lik-Yuen Chan; Steven Woon-Choi Tsang; Chook-Tiew Liew; Chi-Hang Tse; May-Ling Wong; Jessica Yuet-ling Ching; Nancy Wai-Yee Leung; John Siu-Lun Tam; Joseph Jao-Yiu Sung
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

5.  Real time TaqMan PCR detection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard.

Authors:  J Weiss; H Wu; B Farrenkopf; T Schultz; G Song; S Shah; J Siegel
Journal:  J Clin Virol       Date:  2004-05       Impact factor: 3.168

6.  Multicenter evaluation of the VERSANT hepatitis B virus DNA 3.0 assay.

Authors:  Joseph D C Yao; Marcel G H M Beld; Lynette Lin Ean Oon; Christopher H Sherlock; Jeffrey Germer; Sandra Menting; Su Yun Se Thoe; Linda Merrick; Rainer Ziermann; Johan Surtihadi; H James Hnatyszyn
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

7.  Simple technique for internal control of real-time amplification assays.

Authors:  Siegfried Burggraf; Bernhard Olgemöller
Journal:  Clin Chem       Date:  2004-03-09       Impact factor: 8.327

8.  Levels of hepatitis B virus (HBV) replication during the nonreplicative phase: HBV quantification by real-time PCR in Korea.

Authors:  Hyung Joon Yim; Kwan Soo Byun; Yun Jung Chang; Yeon Seok Suh; Jong Eun Yeon; Chang Hong Lee; Jung Ah Kwon; Wangdon Yoo; Soo-Ok Kim; Sun Pyo Hong
Journal:  Dig Dis Sci       Date:  2007-04-11       Impact factor: 3.199

Review 9.  Viral hepatitis B.

Authors:  Ching Lung Lai; Vlad Ratziu; Man-Fung Yuen; Thierry Poynard
Journal:  Lancet       Date:  2003-12-20       Impact factor: 79.321

10.  Clinical evaluation of the digene hybrid capture II test and the COBAS AMPLICOR monitor test for determination of hepatitis B virus DNA levels.

Authors:  He-Jun Yuan; Man-Fung Yuen; Danny Ka-Ho Wong; Simon Siu-Man Sum; Ching-Lung Lai
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

View more
  3 in total

1.  Variations in the S and P regions of the hepatitis B virus genome under immunosuppression in vitro and in vivo.

Authors:  Zhong-Yang Shen; Wei-Ping Zheng; Yong-Lin Deng; Hong-Li Song
Journal:  Viral Immunol       Date:  2012-09-04       Impact factor: 2.257

2.  An in-house real-time polymerase chain reaction: standardisation and comparison with the Cobas Amplicor HBV monitor and Cobas AmpliPrep/Cobas TaqMan HBV tests for the quantification of hepatitis B virus DNA.

Authors:  Ana Paula de Torres Santos; José Eduardo Levi; Marcilio Figueiredo Lemos; Samira Julien Calux; Isabel Takano Oba; Regina Célia Moreira
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-02       Impact factor: 2.743

3.  Dynamic comparison between Daan real-time PCR and Cobas TaqMan for quantification of HBV DNA levels in patients with CHB.

Authors:  Shao-hang Cai; Fang-fang Lv; Yong-hong Zhang; Ye-gui Jiang; Jie Peng
Journal:  BMC Infect Dis       Date:  2014-02-14       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.